Impressive developments at Utrecht Science Park Bilthoven

Date:
Jorrit van Hoorn, USPB

On Thursday 14 November, Utrecht Science Park Bilthoven opened its doors for a unique look behind the scenes. The Utrecht Science Park Café highlighted several impressive topics that are in full development in Bilthoven.

After a brief introduction by Jef de Clerq (CEO Poonawalla Science Park B.V.) and Jan Henk van der Velden ( managing director of the Utrecht Science Park), Jorrit van Hoorn (director of Corporate Development) took us through the latest developments of Utrecht Science Park Bilthoven.

Utrecht Science Park Bilthoven is home to Bilthoven Biologicals (BBio), a major producer of polio vaccines, among other things. BBio also has a crucial role to play in responding to a possible new pandemic. Over the past year, the Pandemic Preparedness Centre has been developed. This centre ensures that enough production capacity is available for vaccine production in possible future emergencies affecting public health.

RIVM, currently still housed in Bilthoven, is scheduled to move to the Utrecht Science Park during 2025. This offers new opportunities for both locations.

The interesting presentation was followed by a tour of Utrecht Science Park Bilthoven, past the special facilities.

Utrecht Science Park Bilthoven

Utrecht Science Park Bilthoven is one of the two satellite locations of the Utrecht Science Park. Bilthoven is home to companies and organisations in the fields of life sciences and sustainability. Utrecht Science Park Bilthoven specialises in product development, product improvement and manufacturing with a focus on vaccines.

Princess Máxima Center and International Atomic Energy Agency join forces to improve radiotherapy treatments for children

In the presence of Her Majesty Queen Máxima, representatives of the Princess Máxima Center and the International Atomic Energy Agency (IAEA) today signed a four-year partnership aimed at improving practical knowledge on the use of radiotherapy for children with cancer.

MedTech plan UMC Utrecht - rapport Wennink

MedTech sector launches national growth plan: technology must support Dutch healthcare and structurally strengthen economic growth

The Dutch MedTech sector is presenting an ambitious growth plan today that aims to elevate the Netherlands to the European top by 2035. UMC Utrecht contributed to this plan, and it was co-presented by Carina Hilders (Chair of the UMC Utrecht Executive Board).

klimwand kalymnos

Parking rates at Utrecht Science Park to change from 1 January 2026

From 1 January 2026, parking rates at Utrecht Science Park will be adjusted. The Municipality of Utrecht and the owners of the publicly accessible parking facilities at Utrecht Science Park have reached a joint agreement on this.

Wennink plan: Life Sciences and biotechnology are important growth drivers for the earning capacity of the Netherlands

The Dutch Life Sciences and biotechnology sector can make a much larger contribution to the Netherlands’ economic strength. This is shown in a new growth strategy presented today as part of Peter Wennink’s advisory report. The report also highlights Utrecht Science Park as one of the key innovation locations and sources of progress and growth.